Literature DB >> 2927041

Role of lymphocytes in dogs experimentally re-challenged with canine transmissible sarcoma.

S Mizuno, T Fujinaga, M Tajima, K Otomo, T Koike.   

Abstract

The role of lymphocytes in dogs re-challenged with canine transmissible sarcoma (CTS) was investigated histologically and immunologically. Tumors were detected on the 3rd day, began to regress on the 9th day and disappeared on approximately the 15th day after the secondary transplantation (AST). The CTS cells were surrounded by lymphocytes which had infiltrated from the early stage, degenerated and ultimately disappeared. Most of the lymphocytes expressed thymocyte antigen (Ta) on the cell membrane surface. The numbers of lymphocytes and Ta-positive lymphocytes in peripheral blood increased gradually AST. The blastogenic responses of peripheral blood lymphocytes (PBL) induced by 3 kinds of mitogens were elevated strikingly from the early stage AST. These results suggest that Ta-positive lymphocytes play an important role in vivo in the regression of tumors and that the immunological activity of PBL is stimulated immediately AST.

Entities:  

Mesh:

Year:  1989        PMID: 2927041     DOI: 10.1292/jvms1939.51.86

Source DB:  PubMed          Journal:  Nihon Juigaku Zasshi        ISSN: 0021-5295


  3 in total

1.  Immunology of naturally transmissible tumours.

Authors:  Hannah V Siddle; Jim Kaufman
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

2.  Canine Parvovirus ns1 gene and Chicken Anemia vp3 gene induce partial oncolysis of Canine Transmissible Venereal Tumor.

Authors:  Aubid Hussain Bhat; Bhaskar Ganguly; Ashok Kumar Tiwari; Arup Kumar Das
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

3.  Intratumoral recombinant human interferon alpha-2a and vincristine combination therapy in canine transmissible venereal tumour.

Authors:  Halit Kanca; Gizem Tez; Kazim Bal; Dogukan Ozen; Eray Alcigir; Sevil Atalay Vural
Journal:  Vet Med Sci       Date:  2018-08-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.